Physician profile
Isha Purang
NPI 1215509369
$469.60
in general payments reported to CMS, 2019-2025
15 companies · $22.59 in 2025
The $22.59 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.11 · 2022: $142 · 2023: $261 · 2025: $22.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.67 | 2022-2023 | Jardiance |
| Novo Nordisk INC | $67.42 | 2022-2023 | Wegovy |
| Lilly USA, LLC | $63.29 | 2022-2023 | Mounjaro, Trulicity |
| Astrazeneca Pharmaceuticals LP | $31.67 | 2022-2023 | Farxiga |
| Abbvie INC. | $22.59 | 2025 | |
| Sanofi Pasteur INC. | $21.90 | 2022 | |
| Seqirus USA INC | $21.87 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Sumitomo Pharma America, INC. | $21.51 | 2023 | Gemtesa |
| Astellas Pharma US INC | $18.89 | 2023 | Myrbetriq |
| Xeris Pharmaceuticals, INC. | $18.12 | 2023 | Gvoke Hypopen |
| Biohaven Pharmaceuticals, INC. | $16.12 | 2021 | |
| Biogen, INC. | $15.20 | 2021 | |
| Merck Sharp & Dohme LLC | $14.50 | 2022 | |
| Exact Sciences Corporation | $14.06 | 2023 | Cologuard Collection Kit |
| Endo Pharmaceuticals INC. | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isha Purang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.